Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl L-Carnitine in Obese, Diabetic, Postmenopausal Women With Osteoarthritis
NCT07660081Completed
- Sponsor
- Khyber Medical University
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in osteoarthritis (OA) comparing Acetyl L-Carnitine Group with Placebo Control Group (2 arms). Primary endpoints: Serum C-Reactive Protein Concentration at Week 12, Fasting Blood Glucose Concentration at Week 12 and 10 more. Started Dec 2025; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07660081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07660081.